Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography

被引:52
作者
Cheng, CL
Chou, CH
Hu, OYP
机构
[1] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm, Tainan 70101, Taiwan
[2] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan
[3] Natl Def Med Ctr, Taipei, Taiwan
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2005年 / 817卷 / 02期
关键词
lamotrigine; antiepileptive; HPLC; pharmacokinetics;
D O I
10.1016/j.jchromb.2004.12.004
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Lamotrigine is a broad-spectrum antiepileptic agent. This study describes a simple and sensitive high-performance liquid chromatographic method for the determination of lamotrigine in 50 mul of plasma. Lamotrigine and the internal standard guanabenz were extracted with 1.2 ml of diethyl ether, after the samples alkalinized with 10 mul of sodium hydroxide solution (1N). Chromatographic separation was achieved on a silica column with the mobile phase of acetonitrile-water containing 0.2% phosphoric acid and 0.3% triethylamine (pH 2.7) (84:16, v/v), at a flow-rate of 1 ml/min. The eluant was detected at 225 nm. The retention time was about 6 min for lamotrigine and 7 min for guanabenz. No endogenous substances and concomitant anticonvulsants were found to interfere. Calibration curves were linear from 0.1 to 5 mug/ml. The relative recovery of lamotrigine averaged about 80%. The limit of quantitation was 0.1 mug/ml. The intra- and inter-day precision (expressed as coefficient of variation, CV) was 8.1%, or less, and the accuracy was within 11.5% deviation of the nominal concentration. The method is suitable in pharmacokinetic investigation and monitoring lamotrigine concentration. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:199 / 206
页数:8
相关论文
共 30 条
[1]   Determination of lamotrigine in human plasma by high-performance liquid chromatography [J].
Angelis-Stoforidis, P ;
Morgan, DJ ;
O'Brien, TJ ;
Vajda, FJE .
JOURNAL OF CHROMATOGRAPHY B, 1999, 727 (1-2) :113-118
[2]   Validated high-performance liquid chromatographic method for the determination of lamotrigine in human plasma [J].
Barbosa, NR ;
Mídio, AF .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 741 (02) :289-293
[3]   A rapid and specific assay for the determination of lamotrigine in human plasma by normal-phase HPLC [J].
Bartoli, A ;
Marchiselli, R ;
Gatti, G .
THERAPEUTIC DRUG MONITORING, 1997, 19 (01) :100-107
[4]   Lamotrigine drug interactions in a TDM material [J].
Böttiger, Y ;
Svensson, JO ;
Ståhle, L .
THERAPEUTIC DRUG MONITORING, 1999, 21 (02) :171-174
[5]   Lamotrigine analysis in blood and brain by high-performance liquid chromatography [J].
Castel-Branco, MM ;
Almeida, AM ;
Falcao, AC ;
Macedo, TA ;
Caramona, MM ;
Lopez, FG .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2001, 755 (1-2) :119-127
[6]   Rapid and sensitive quantitation of the antiproliferative agent mitoguazone in small volumes of plasma by high-performance liquid chromatography with ultraviolet detection [J].
Cheng, CL ;
Lin, EG ;
Chou, CH .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 793 (02) :281-289
[7]   Determination of metformin in human plasma by high-performance liquid chromatography with spectrophotometric detection [J].
Cheng, CL ;
Chou, CH .
JOURNAL OF CHROMATOGRAPHY B, 2001, 762 (01) :51-58
[8]   A validated HPLC method with ultraviolet detection for the determination of buformin in plasma [J].
Chou, CH ;
Cheng, CL ;
Huang, CC .
BIOMEDICAL CHROMATOGRAPHY, 2004, 18 (04) :254-258
[9]   PERFORMANCE ANALYSIS OF A REVERSED-PHASE LIQUID-CHROMATOGRAPHIC ASSAY OF LAMOTRIGINE IN PLASMA USING SOLVENT-DEMIXING EXTRACTION [J].
COCIGLIO, M ;
ALRIC, R ;
BOUVIER, O .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 572 (1-2) :269-276
[10]   LAMOTRIGINE, A NEW ANTICONVULSANT - PHARMACOKINETICS IN NORMAL HUMANS [J].
COHEN, AF ;
LAND, GS ;
BREIMER, DD ;
YUEN, WC ;
WINTON, C ;
PECK, AW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (05) :535-541